SIETES :: 92559 citas

Resultados de la búsqueda por TOPIRAMATO REFINAR BÚSQUEDA

1.

Enke O, New HA, New CH, Mathieson S, McLachlan AJ, Latimer J, Maher CG, Lin CC. Anticonvulsants in the treatment of low back pain and lumbar radicular pain: a systematic review and meta-analysis. Can Med Assoc J 2018;190:E786-93. [Ref.ID 102754]

2.

Maust DT, Kim M, Chiang C, Kales HC. Association of the Centers for Medicare & Medicaid Services’ National Partnership to Improve Dementia Care with the use of antipsychotics and other psychotropics in long-term care in the United States from 2009 to 2014. JAMA Intern Med 2018;178:mayo. [Ref.ID 102698]

3.

Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson EE, Brochado AR, Fernandez KC, Dose H, Mori H, Patil KR, Bork P, Typas A. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 2018;555:29 de marzo. [Ref.ID 102577]

4.

Pennel PB. Prescribing antiepileptic drugs to women of reproductive age. Lancet Neurol 2018;17:485-6. [Ref.ID 102517]

5.

Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Perucca E, Sabers A, Thomas SV, Vajda F, for the EURAP study group. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. Lancet Neurol 2018;17:530-8. [Ref.ID 102516]

6.

Varadkar S. Cannabidiol for drop seizures in Lennox-Gastaut syndrome. Lancet 2018;391:1006-7. [Ref.ID 102474]

7.

Thiele EA, French ED, French JA, Mazurkiewicz-Beldzinska M, Benbadis SR, Joshi C, Lyons PD, Taylor A, Roberts C, Sommerville K, on behalf of the GWPCARE4 Study Group. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2018;391:24 de enero. [Ref.ID 102450]

8.

Bjørk M, Riedel B, Spiqset O, Veiby G, Kolstad E, Daltveit AK, Gilhus NE. Association of folic acid supplementation during pregnancy with the risk of autistic traits in children exposed to antiepileptic drugs In utero. JAMA Neurology 2017:26 de diciembre. [Ref.ID 102193]

9.

Bromley RL, Weston J, Marson AG. Maternal use of antiepileptic agents during pregnancy and major congenital malformations in children. JAMA 2017;318:1700-1. [Ref.ID 102140]

10.

Pinto RZ, Verwoerd AJH, Koes BW. Which pain medications are effective for sciatica (radicular leg pain)?. BMJ 2017;359:j4248. [Ref.ID 102095]

11.

Zaccara G, Giovannelli F, Giorgi FS, Franco V, Gasparini S, Benedetto U. Tolerability of new antiepileptic drugs: a network meta-analysis. Eur J Clin Pharmacol 2017;73:811-7. [Ref.ID 101994]

12.

Powers SW, Coffey CS, Chamberlin LA, Ecklund DJ, Klingner EA, Yankey JW, Korbee LL, Porter LL, Hershey AD, for the CHAMP Investigators. Trial of amitriptyline, topiramate, and placebo for pediatric migraine. N Engl J Med 2017;376:115-24. [Ref.ID 101371]

13.

Anónimo. Topiramate, zonisamide: panilopsies. Prescrire 2016;36:666. [Ref.ID 100822]

14.

Baftiu A, Landmark CJ, Rusten IR, Feet SA, Johannessen SI, Larsson PG. Changes in utilisation of antiepileptic drugs in epilepsy and non-epilepsy disorders - A pharmacoepidemiological study and clinical implications. Eur J Clin Pharmacol 2016;72:1245-54. [Ref.ID 100799]

15.

Anónimo. Pérampanel et épilepsies généralisées réfractaires. Prescrire 2016;36:492-3. [Ref.ID 100550]

16.

Khera R, Murad MH, Chandar AK, Dulai PS, Wang Z, Prokop LJ, Loomba R, Camilleri M, Singh S. Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis. JAMA 2016;315:2424-34. [Ref.ID 100458]

17.

Anónimo. Riesgo de miopatía y glaucoma por zonisamida. Butlletí de Farmacovigilància de Catalunya 2015;13:15-6. [Ref.ID 99834]

18.

Anónimo. Diet, drugs, and surgery for weight loss. Med Lett Drugs Ther 2015;57:21-8. [Ref.ID 98856]

19.

Gual A, Miquel L. Nuevas perspectivas para el tratamiento del alcoholismo. Med Clin (Barc) 2015;144:24-5. [Ref.ID 98707]

20.

Ferrer P, Rafaniello C, Sabaté M, Ballarín E, Coma A, Zara C, Capuano A, Rossi F, Laporte JR, Ibáñez L. Cross-national comparison of antiepileptic drug use: Catalonia, Denmark and Norway, 2007-2011. Epidemiology Biostatistics and Public Health 2014;11:e9405-9409. [Ref.ID 98375]